Application no. and date | 17195530.5 (espacenet) (Federated) (European Patent Register), 20110112 | Patent/reg. no. and date | DK/EP 3295957, 20190807 | Publication date | 20180321 | Priority no. and date | US 295387 P, 20100115, US 422059 P, 20101210 | EP pub. no. and date |
EP 3295957 20180321 | Effective date | | Applicant/owner | Kirin-Amgen, Inc., One Amgen Center Drive
Thousand Oaks CA 91320-1799, US | Applicant ref. no. | P69808DK01 | Inventor | LIU, Dingjiang, 766 Bellagio Court
Oak Park, CA 91377, US, HUANG, Holly Zhuohong, 1792 Amarelle Street
Thousand Oaks, CA 91320, US, MARTIN, David Andrew, 6515 20th Avenue NE
Seattle, WA 98115, US, RUSSELL, Christopher Boyd, 3570 Crystal Springs Dr. NE
Bainbridge Island, WA 98110, US, SALINGER, David H., 6234 29th Avenue NE
Seattle, WA 98115, US, BAUMGARTNER, Scott Walter, 3020 Hollycrest Avenue
Thousand Oaks, CA 91362, US, ENDRES, Christopher J., 3258 NW Market Street
Seattle, WA 98107, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | Opponent | | IPC Class | A61K 39/395 (2006.01) , A61P 17/06 (2006.01) , C07K 16/28 (2006.01) | Title | ANTI IL-17RA-ANTISTOFFORMULERING OG TERAPEUTISKE REGIMENER TIL BEHANDLING AF PSORIASIS | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|